has been cited by the following article(s):
[1]
|
Studies on pomegranate seed oil enriched galantamine hydrobromide microemulsion: formulation, in vitro antioxidant and neuroprotective potential
Pharmaceutical Development and Technology,
2023
DOI:10.1080/10837450.2023.2171433
|
|
|
[2]
|
Studies on pomegranate seed oil enriched galantamine hydrobromide microemulsion: formulation, in vitro antioxidant and neuroprotective potential
Pharmaceutical Development and Technology,
2023
DOI:10.1080/10837450.2023.2171433
|
|
|
[3]
|
Studies on pomegranate seed oil enriched galantamine hydrobromide microemulsion: formulation, in vitro antioxidant and neuroprotective potential
Pharmaceutical Development and Technology,
2023
DOI:10.1080/10837450.2023.2171433
|
|
|
[4]
|
Growing role of S100B protein as a putative therapeutic target for neurological- and nonneurological-disorders
Neuroscience & Biobehavioral Reviews,
2021
DOI:10.1016/j.neubiorev.2021.04.035
|
|
|
[5]
|
Growing role of S100B protein as a putative therapeutic target for neurological- and nonneurological-disorders
Neuroscience & Biobehavioral Reviews,
2021
DOI:10.1016/j.neubiorev.2021.04.035
|
|
|
[6]
|
Biodistribution and amyloid beta induced cell line toxicity study of intranasal Rivastigmine microemulsion enriched with Fish Oil and Butter oil
Journal of Drug Delivery Science and Technology,
2020
DOI:10.1016/j.jddst.2020.101661
|
|
|
[7]
|
S100 Proteins in Alzheimer’s Disease
Frontiers in Neuroscience,
2019
DOI:10.3389/fnins.2019.00463
|
|
|